Merck presents positive results from phase-II/III study
Broad phase-III clinical programme for V116 in vaccine-naïve and vaccine-experienced adults planned to start in July 2022
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Pneumococcal Conjugate Vaccine
Dr Mansukh Mandaviya launches nation-wide expansion of PCV
Addressing the nation-wide rollout, the Union Minister said that it is for the first time in the country that PCV will be…
Aurobindo Pharma joins COVID-19 vaccine hunt
The company’s vaccine candidate has been shortlisted for BIRAC funding, will launch final product by the end of 2022